Refractory Burkitt Leukemia
1 clinical trials · Condition
◉ Watch Refractory Burkitt Leukemia
| Record | Firm | Date |
|---|---|---|
| Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia (NCT03136146) | M.D. Anderson Cancer Center | 2017-08-09 |
Track Refractory Burkitt Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.